CN103860676B - 一种治疗腰肌劳损的中药外用制剂及其制备方法 - Google Patents
一种治疗腰肌劳损的中药外用制剂及其制备方法 Download PDFInfo
- Publication number
- CN103860676B CN103860676B CN201410073097.9A CN201410073097A CN103860676B CN 103860676 B CN103860676 B CN 103860676B CN 201410073097 A CN201410073097 A CN 201410073097A CN 103860676 B CN103860676 B CN 103860676B
- Authority
- CN
- China
- Prior art keywords
- parts
- muscle strain
- lumbar muscle
- chinese medicine
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 74
- 206010050031 Muscle strain Diseases 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 238000011282 treatment Methods 0.000 title claims description 50
- 241000903946 Clematidis Species 0.000 claims abstract description 20
- 241001057584 Myrrha Species 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 20
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 19
- 239000004863 Frankincense Substances 0.000 claims abstract description 19
- 241000237636 Pheretima Species 0.000 claims abstract description 14
- 241001489978 Eupolyphaga Species 0.000 claims abstract description 13
- 238000010438 heat treatment Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000004821 distillation Methods 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 230000008901 benefit Effects 0.000 claims description 16
- 239000011505 plaster Substances 0.000 claims description 14
- 238000000108 ultra-filtration Methods 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- 239000002674 ointment Substances 0.000 claims description 12
- 239000007921 spray Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 239000013078 crystal Substances 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 230000003203 everyday effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 6
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 6
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 4
- 238000010410 dusting Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 239000000571 coke Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- -1 tincture Substances 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 57
- 230000017531 blood circulation Effects 0.000 abstract description 24
- 230000001717 pathogenic effect Effects 0.000 abstract description 21
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 210000001519 tissue Anatomy 0.000 abstract description 10
- 230000002175 menstrual effect Effects 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract description 7
- 230000035876 healing Effects 0.000 abstract description 6
- 230000002061 histotrophic effect Effects 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 239000008280 blood Substances 0.000 description 77
- 210000004369 blood Anatomy 0.000 description 75
- 210000003734 kidney Anatomy 0.000 description 66
- 208000002193 Pain Diseases 0.000 description 57
- 230000036407 pain Effects 0.000 description 56
- 210000001624 hip Anatomy 0.000 description 55
- 210000003205 muscle Anatomy 0.000 description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 29
- 201000010099 disease Diseases 0.000 description 28
- 208000006820 Arthralgia Diseases 0.000 description 27
- 210000004185 liver Anatomy 0.000 description 26
- 238000012360 testing method Methods 0.000 description 23
- 208000008035 Back Pain Diseases 0.000 description 22
- 230000007812 deficiency Effects 0.000 description 22
- 210000000988 bone and bone Anatomy 0.000 description 19
- 208000008930 Low Back Pain Diseases 0.000 description 18
- 230000008961 swelling Effects 0.000 description 16
- 206010042674 Swelling Diseases 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 210000003462 vein Anatomy 0.000 description 14
- 210000001015 abdomen Anatomy 0.000 description 12
- 230000000202 analgesic effect Effects 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 201000000736 Amenorrhea Diseases 0.000 description 10
- 206010001928 Amenorrhoea Diseases 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 10
- 231100000540 amenorrhea Toxicity 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 10
- 210000003041 ligament Anatomy 0.000 description 10
- 230000036544 posture Effects 0.000 description 10
- 208000025747 Rheumatic disease Diseases 0.000 description 9
- 230000000552 rheumatic effect Effects 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 210000001367 artery Anatomy 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 230000033001 locomotion Effects 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 210000002435 tendon Anatomy 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000004089 microcirculation Effects 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 208000037920 primary disease Diseases 0.000 description 7
- 206010040880 Skin irritation Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 238000005452 bending Methods 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000006735 deficit Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 210000003141 lower extremity Anatomy 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 206010062575 Muscle contracture Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 208000006111 contracture Diseases 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000002040 relaxant effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 241000700199 Cavia porcellus Species 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 238000009499 grossing Methods 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 210000002097 psoas muscle Anatomy 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 231100000041 toxicology testing Toxicity 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 3
- 208000008967 Enuresis Diseases 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000002052 anaphylactic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000010339 dilation Effects 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 241000345998 Calamus manan Species 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241001506371 Kadsura Species 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- 208000001294 Nociceptive Pain Diseases 0.000 description 2
- 208000005141 Otitis Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- 241000758706 Piperaceae Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010058907 Spinal deformity Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000019804 backache Diseases 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 229960001259 diclofenac Drugs 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 208000018937 joint inflammation Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 238000002078 massotherapy Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- VTRAEEWXHOVJFV-UHFFFAOYSA-N olmesartan Chemical compound CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 VTRAEEWXHOVJFV-UHFFFAOYSA-N 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000001050 pharmacotherapy Methods 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 235000012950 rattan cane Nutrition 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 206010056377 Bone tuberculosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000003899 Foreign-Body Granuloma Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000002038 Muscle Hypertonia Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000020307 Spinal disease Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229960005466 diclofenac diethylammonium Drugs 0.000 description 1
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000003131 sacroiliac joint Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000005198 spinal stenosis Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 动物数 | 肿胀度(mg) |
模型对照组 | 12 | 14.38±2.16 |
阳性对照组 | 12 | 4.19±0.99*** |
本发明高剂量组 | 12 | 4.59±1.78** |
本发明中剂量组 | 12 | 5.23±1.82* |
本发明低剂量组 | 12 | 8.16±2.52* |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410073097.9A CN103860676B (zh) | 2014-02-28 | 2014-02-28 | 一种治疗腰肌劳损的中药外用制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410073097.9A CN103860676B (zh) | 2014-02-28 | 2014-02-28 | 一种治疗腰肌劳损的中药外用制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103860676A CN103860676A (zh) | 2014-06-18 |
CN103860676B true CN103860676B (zh) | 2016-03-23 |
Family
ID=50900063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410073097.9A Active CN103860676B (zh) | 2014-02-28 | 2014-02-28 | 一种治疗腰肌劳损的中药外用制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103860676B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104117019A (zh) * | 2014-07-25 | 2014-10-29 | 刘军 | 一种治疗慢性腰扭伤的中药制剂 |
CN104189670A (zh) * | 2014-08-18 | 2014-12-10 | 冷江 | 一种治疗运动型腰肌劳损的药膏 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1310014A (zh) * | 2001-02-20 | 2001-08-29 | 叶庆莲 | 一种治疗腰疼的中药 |
CN100411665C (zh) * | 2005-06-15 | 2008-08-20 | 艾立明 | 一种治疗疼痛症的外敷中药药物袋 |
CN101138625A (zh) * | 2006-09-05 | 2008-03-12 | 邓艳青 | 一种治疗肩关节炎的中药组合物 |
-
2014
- 2014-02-28 CN CN201410073097.9A patent/CN103860676B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103860676A (zh) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860667B (zh) | 一种治疗腰肌劳损的中药组合物及其制备方法 | |
CN101810685B (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
CN103751310B (zh) | 一种治疗筋膜炎的中药外用制剂及其制备方法 | |
CN102793883B (zh) | 一种治疗椎间盘突出、颈椎病的膏药 | |
CN104306495B (zh) | 一种治疗肩周炎的中药外用制剂及其制备方法 | |
CN103768567B (zh) | 一种黑膏药及其制备方法 | |
CN104666698A (zh) | 一种治疗膝关节滑膜炎的中药外用膏剂及其制备方法 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN104367665A (zh) | 一种治疗肩周炎的中药组合物及其制备方法 | |
CN102872286B (zh) | 一种治疗腰间盘突出的中药组合物及其制备方法 | |
CN101040930B (zh) | 一种外用治疗腰椎间盘突出的中药组合物 | |
CN104435169A (zh) | 一种治疗骨伤骨折的中药组合物及其制备方法 | |
CN103768531B (zh) | 用于治疗类风湿关节炎的中药组合物及其制备方法 | |
CN104940868A (zh) | 一种治疗颈椎病的中药配方及颈椎贴 | |
CN103860676B (zh) | 一种治疗腰肌劳损的中药外用制剂及其制备方法 | |
CN105998246A (zh) | 一种治疗足跟痛的中药外用膏剂及其制备方法 | |
CN105878776A (zh) | 治疗颈肩腰腿病的药物组合物、制剂及其制备方法和应用 | |
CN103100017B (zh) | 一种缓解筋骨疼痛、关节疼痛的中药保健品及其制备方法 | |
CN104398962A (zh) | 一种治疗脾肾两虚型腰肌劳损的中药组合物及其制备方法 | |
CN104474114A (zh) | 一种治疗肾阳虚型腰肌劳损的中药组合物及其制备方法 | |
CN105920130A (zh) | 治疗足跟痛的中药制备方法及其外用膏剂 | |
CN103751467A (zh) | 一种治疗腰背筋膜炎的中药组合物及其制备方法 | |
CN104306583A (zh) | 一种治疗月经量少的中药组合物及其制备方法 | |
CN103735725B (zh) | 用于治疗猪风湿病的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160218 Address after: 266001 Shandong city of Qingdao province Chongqing District Road No. 27 Building No. 1 room 402, unit 2 Applicant after: Zhang Xuwei Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Applicant before: Qingdao Hengbo Instrument Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 210000 Xinlian Pioneer Park, 70 Matai Street, Gulou District, Nanjing City, Jiangsu Province Patentee after: Zhang Xuwei Address before: 266001 room 2, unit 1, 27 Chongqing South Road, Shibei District, Qingdao, Shandong, 2 Patentee before: Zhang Xuwei |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: No. 666, Changcheng Road, Chengyang District, Qingdao City, Shandong Province Patentee after: Zhang Xu Wei Address before: 210000 Xinlian Pioneer Park, 70 Matai Street, Gulou District, Nanjing City, Jiangsu Province Patentee before: Zhang Xu Wei |
|
CP02 | Change in the address of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191021 Address after: 314500, building 288, 2 Avenue, Indus street, Tongxiang, Zhejiang, Jiaxing Patentee after: Zhejiang harvest Network Technology Co., Ltd. Address before: No. 666, Changcheng Road, Chengyang District, Qingdao City, Shandong Province Patentee before: Zhang Xu Wei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200426 Address after: 363000 No.16, Weihui Road, Suian Industrial Zone, Zhangpu County, Zhangzhou City, Fujian Province Patentee after: Fujian tongyitangguo Pharmaceutical Development Co., Ltd Address before: 314500, building 288, 2 Avenue, Indus street, Tongxiang, Zhejiang, Jiaxing Patentee before: ZHEJIANG MAIZHI NETWORK TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |